Latest Product News
MAPS and Wesana Health Resume Final Negotiations
Analysis indicates viability of research pathway for MDMA-assisted therapy to treat symptoms associated with traumatic brain injury.
High Productivity Photochemical Flow Synthesis
Asynt reports upon a new paper that describes how the fReactor flow chemistry system with add-on photochemical flow modules improves synthetic reactions commonly used in the preparation of drug intermediates.
Eppendorf Donates 20,000 Euros to the EMBL to Promote Women Working in Science
Eppendorf SE has donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields.
Advanced tools for Glycobiology research
AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support.
Emulate Introduces the Second-Generation Zoë® Culture Module for Replicating Complex Human Biology and Drug Effect
Emulate has launched the Zoë-CM2™ Culture Module, a second-generation Zoë instrument that is at the core of their Human Emulation System®.
Synthace Raises $35M to Expand Access to Its R&D Technology for Research
Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 million in Series C funding
Validity of AI in Life Sciences Proven Through Pangaea Data’s Novel Natural Language Generation Driven Product
A Senior Principal Data Scientist from a leading global pharmaceutical company showcased its success stories of using Pangaea Data’s novel artificial intelligence driven product, PIES (Pangaea’s Intelligence Extractor and Summarization).
Generating Cell Repellent Surfaces in Microfluidic Devices
AMSBIO report that researchers from the Medical University of Vienna (Austria), have used Lipidure® - CM5206 to coat channels in their novel microfluidic devices, to prevent cell adhesion.
Ferrer and Treeway Enter Into Licence Agreement for the Development and Commercialisation of TW001/FNP122 for Amyotrophic Lateral Sclerosis
Ferrer and Treeway have announced they have entered into a license agreement for the development and commercialization of an oral formulation of edaravone for Amyotrophic Lateral Sclerosis.
RareCan Receives Approval from NHS Research Ethics Committee To Establish Vital BioResource at Newcastle University
RareCan a novel company accelerating research into rare cancers, has announced it has received approval from the NHS Research Ethics Committee to establish its BioResource at Newcastle University.